Lipoprotein‐Associated Phospholipase A <sub>2</sub> Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease
Journal of the American Heart Association. Cardiovascular and cerebrovascular disease